GlassScriptPhysician profile
Frank P Schinco
NPI 1356384960
$6,908.74
in general payments reported to CMS, 2019-2025
26 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $297 · 2021: $544 · 2022: $293 · 2023: $378 · 2024: $4,999 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,630 · Travel and Lodging: $1,092 · Food and Beverage: $917 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,630.00 |
| Travel and Lodging | $1,092.36 |
| Food and Beverage | $916.79 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $4,722.36 | 2024 | Velys |
| Abbott Laboratories | $813.83 | 2019-2025 | Proclaim |
| Depuy Synthes Sales INC. | $333.04 | 2019-2025 | Matrixneuro, Trumatch |
| Medtronic, INC. | $201.95 | 2021-2024 | Activos 10 Bone Cement, Accurian, Midas Rex |
| Intrinsic Therapeutics | $115.08 | 2025 | Barricaid Acd (Annular Closure Device) |
| Piramal Critical Care | $80.88 | 2022-2024 | |
| Si-Bone, INC. | $78.04 | 2023 | |
| Boston Scientific Corporation | $53.67 | 2020 | |
| Depuy Synthes Products, INC. | $48.51 | 2024 | Velys |
| Gt Medical Technologies, INC | $45.62 | 2021 | |
| Livanova USA, INC. | $37.18 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Medtronic USA, INC. | $35.66 | 2019-2020 | |
| Nevro Corp. | $33.65 | 2019 | |
| Heron Therapeutics, INC. | $31.16 | 2021-2024 | Zynrelef |
| Penumbra, INC. | $30.30 | 2020-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $28.49 | 2020-2023 | Spinal-Stim, Cervical-Stim |
| Globus Medical, INC. | $27.48 | 2025 | Vyrsa V1 |
| Kls-Martin L.P. | $27.01 | 2024 | |
| Tersera Therapeutics LLC | $26.98 | 2021 | |
| Stryker Corporation | $22.53 | 2022 | |
| Azurity Pharmaceuticals, INC. | $22.36 | 2023 | Gliadel |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Pfizer INC. | $19.58 | 2025 | |
| Radius Health, INC. | $19.40 | 2023 | Tymlos |
| Carlsmed, INC. | $18.09 | 2023 | Aprevo |
| Integra Lifesciences Corporation | $15.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Schinco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.